Microbial Efflux Pump Inhibitors: A Journey around Quinoline and Indole Derivatives
Antimicrobial resistance (AMR) is a complex threat to human health and, to date, it represents a hot topic in drug discovery. The use of non-antibiotic molecules to block resistance mechanisms is a powerful alternative to the identification of new antibiotics. Bacterial efflux pumps exert the early...
Enregistré dans:
Auteurs principaux: | Giada Cernicchi, Tommaso Felicetti, Stefano Sabatini |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e79a2cf4b97140a097c7c5abf29c00a3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump
par: Elizabeth M. Grimsey, et autres
Publié: (2020) -
Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets
par: Lauren E. Brooks, et autres
Publié: (2018) -
Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition
par: Ariel M. Langevin, et autres
Publié: (2020) -
Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> Mutants Overexpressing Efflux Pumps
par: Jorge Olivares Pacheco, et autres
Publié: (2017) -
Combating Drug-Resistant Bacteria Using Photothermally Active Nanomaterials: A Perspective Review
par: Kawaljeet Kaur, et autres
Publié: (2021)